Bill > SB109

This bill requires health insurance plans in Oklahoma to provide coverage for certain genetic testing and cancer imaging services without charging annual deductibles, copayments, or coinsurance. Specifically, the bill mandates coverage for clinical genetic testing for inherited gene mutations and evidence-based cancer imaging for individuals with personal or family history of cancer or increased cancer risk. These services must be ordered or recommended by a healthcare provider and align with guidelines from reputable sources like the National Comprehensive Cancer Network (NCCN) clinical practice recommendations or other nationally recognized clinical practice guidelines. The bill defines key terms such as "clinical utility" and "genetic testing for an inherited mutation" and ensures that these services are covered when they provide meaningful medical benefit. The legislation also includes a provision to maintain health savings account eligibility, allowing the coverage to apply to high-deductible health plans either after the minimum deductible is met or for preventive care services. The bill is set to become effective on November 1, 2025, and aims to improve access to important cancer screening and genetic testing services for Oklahoma residents.